XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Tables)
3 Months Ended
Apr. 02, 2021
Segment Reconciliation [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table presents sales by product line (in thousands).
 Three Months Ended
April 2,
2021
April 3,
2020
Segment sales by product line:
Medical
Cardio & Vascular$149,165 $179,205 
Cardiac & Neuromodulation108,408 107,820 
Advanced Surgical, Orthopedics & Portable Medical25,392 31,237 
Total Medical282,965 318,262 
Non-Medical7,502 10,164 
Total sales$290,467 $328,426 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
The following table presents income for the Company’s reportable segments (in thousands).
 Three Months Ended
April 2,
2021
April 3,
2020
Segment income:
Medical$55,525 $65,216 
Non-Medical1,213 
Total segment income55,527 66,429 
Unallocated operating expenses
(20,919)(22,353)
Operating income34,608 44,076 
Unallocated expenses, net(9,630)(7,437)
Income before taxes$24,978 $36,639